Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy

Introduction: Many studies have focused on the role of programmed death receptor ligand 1 (PD-L1) expression in predicting immunotherapy outcomes. Limited clinical data are available regarding the role of programmed death receptor 1 (PD-1; the PD-L1 receptor) expressing tumor-infiltrating lymphocyte...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nicholas J. Bevins, Ryosuke Okamura, Meagan Montesion, Jacob J. Adashek, Aaron M. Goodman, Razelle Kurzrock
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Innovative Healthcare Institute 2022-11-01
Colecção:	Journal of Immunotherapy and Precision Oncology
Assuntos:	immune checkpoint inhibition tumor infiltrating lymphocyte immunotherapy
Acesso em linha:	https://theijpt.org/doi/pdf/10.36401/JIPO-22-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!